Researchers from Nanjing University of Chinese Medicine leveraged ultrahigh-pressure liquid chromatography coupled to quadrupole time-of-flight mass spectrometry (UHPLC–QTOF-MS) and network pharmacology to identify potential quality markers of three processed Qingpi products and elucidate their mechanism in liver disease treatment.
A new study out of Nanjing University of Chinese Medicine in Nanjing, China, published in the Journal of Separation Science, presents findings on the analysis of potential quality markers of three processed products of Qingpi, a traditional Chinese medicine often used in liver disease treatment (1). Led by Qian Zhang and colleagues, the study employed advanced analytical techniques and computational methods to unravel the pharmacological properties of Qingpi.
Dried tangerine peel isolated on white background | Image Credit: © leungchopan - stock.adobe.com
The team utilized an approach coupling ultrahigh-pressure liquid chromatography to quadrupole time-of-flight mass spectrometry (UHPLC–QTOF-MS), in turn coupled with multivariate statistical analysis, to evaluate the differences among the processed Qingpi products and identify potential quality markers. This method allowed for the precise identification of 18 components, laying the groundwork for further investigation into the therapeutic properties of Qingpi.
Moreover, the researchers conducted a comprehensive analysis integrating network pharmacology and molecular docking to elucidate the potential mechanisms underlying Qingpi's efficacy in liver disease treatment. By constructing an integrated network linking Qingpi components, target proteins, pathways, and liver disease, the team identified eight compounds as potential quality markers. These markers were found to interact with ten key targets and pathways associated with liver disease, as revealed by molecular docking simulations.
The findings of this study provide valuable insights into the pharmacological basis of Qingpi's therapeutic effects on liver disease. By identifying potential quality markers and elucidating their mechanisms of action, the researchers have paved the way for further exploration of Qingpi's pharmacodynamic substances and therapeutic mechanisms.
This research contributes to the growing body of knowledge on traditional Chinese medicine and highlights the importance of integrating advanced analytical techniques with computational methods in drug discovery and development. Moving forward, the identified quality markers and their associated targets and pathways could serve as valuable targets for future pharmacological studies aimed at optimizing the therapeutic efficacy of Qingpi and other traditional herbal medicines.
In conclusion, the study by Zhang et al. represents a significant step forward in the analysis of traditional Chinese medicines, providing valuable insights into the pharmacological properties of processed Qingpi products and their potential in liver disease treatment.
This article was written with the help of artificial intelligence and has been edited to ensure accuracy and clarity. You can read more about our policy for using AI here.
(1) Zhang, Q.; Xu, R.; Xue, R.; et al. Ultra-High-Performance Liquid Chromatography-Quadrupole-Time of Flight-Mass Spectrometry Combined with Network Pharmacology for Analysis of Potential Quality Markers of Three Processed Products of Qingpi. J. Sep. Sci. 2024, 47 (1), 2300281. DOI: https://doi.org/10.1002/jssc.202300281
Carol Robinson Awarded 2024 Lifetime Achievement European Inventor Award
July 24th 2024Carol Robinson of the University of Oxford has received the European Inventor Award 2024 for Lifetime Achievement from the European Patent Office for her work bringing mass spectrometry to structural biology.
Microseparations and Analysis Covered at HPLC 2024
July 23rd 2024At HPLC 2024 in Denver, Colorado, various sessions will be led by experienced scientists, covering different aspects of chromatography techniques and maximizing their effectiveness. Here is some information about tomorrow’s sessions.
Automated LC Method Development: An HTC-18 Interview with Bob Pirok
July 23rd 2024At HTC-18 in Leuven, Executive Editor of LCGC International, Alasdair Matheson, spoke to this year’s winner of the 2024 HTC-18 Innovation Award, Bob Pirok from the University of Amsterdam, about his innovative research on automated LC method development.